Skip to main content
. 2003 Nov;41(11):5302–5307. doi: 10.1128/JCM.41.11.5302-5307.2003

TABLE 3.

Summary of reported cases of invasive Chaetomium infections

Patient or reference Age (y)/sex Underlying medical conditiona Site of infection Speciesb Treatment Outcome
Patient 1 47/F Leukemia/umbilical cord blood transplant Multiple organs C. perlucidum L-AMB Death
Patient 2 78/F Asthma/chronic bronchiectasis Lung C. perlucidum RML lobectomy Cure
11 19/F Lymphoma/autologous BMT Lung pleura C. globosum* Tienamycin, vancomycin, amikacin, AMB Death
21 19/M AML Lung Chaetomium sp.** Liposomal AMB Death
9, 17 31/M Multiple myeloma/allogeneic BMT Brain, lung C. atrobrunneum AMB, ITC Death
1 28/M IVDU Brain C. strumarium Oxacillin, cefotaxime, metronidazole Death
1 25/M IVDU Brain C. strumarium Amoxicillin, chloramphenicol, acyclovir, AMB, rifampin, isoniazid Death
1 20/M IVDU Brain C. strumarium Ceftriaxone, penicillin, acyclovir Death
10 24/M ALL Lung C. globosum AMB Death
2 32/M Renal transplant Brain C. atrobrunneum Unknown Death
4 73/F None Left maxillary sinus Chaetomium sp. Infundibulectomy Cure
a

Abbreviations: BMT, bone marrow transplant; RML, right middle lobe; IVDU, intravenous drug user; AML, acute myelogenous leukemia; ALL, acute lymphocytic leukemia.

b

*, there was no tissue invasion, and the authors were unable to determine the role of the organism in the death of the patient; **, the identification of this strain as C. globosum in the original reference has been questioned (7); †, this species is considered to be synonymous with C. cochliodes (18) (the isolate failed to produce fertile acomata for species identification); ‡, this strain was previously identified as C. globosum (1).